Financials

Discussions Technicals Seasonals

042520 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to HANS BIOMED CORPORATION operating, investing, and financing activities

042520 free cash flow for Q3 24 is -540.38 M KRW. For 2023, 042520 free cash flow was -5.66 B KRW and operating cash flow was -3.73 B KRW.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—